Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan

Respirology

Volumn 11, Issue SUPPL. 1, 2006, Pages

  Inoue, Yoshikazu ^a   Nakata, Koh ^b   Arai, Toru ^a   Tazawa, Ryushi ^c   Hamano, Emi ^d   Nukiwa, Toshihiro ^c   Kudo, Koichiro ^d   Keicho, Naoto ^d   Hizawa, Nobuyuki ^e   Yamaguchi, Etsuro ^f   Eda, Ryosuke ^g   Oishi, Kazunori ^h   Maeda, Yuuka ^a   Koreeda, Yukiko ^a   Kodo, Naohiko ^a   Sakatani, Mitsunori ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f AICHI MEDICAL UNIVERSITY   (Japan)

^g NATIONAL SANYO HOSPITAL   (Japan)

^h NAGASAKI UNIVERSITY   (Japan)

Author keywords

Biological markers; Epidemiology; Granulocyte macrophage colony stimulating factor; Prognosis; Pulmonary alveolar proteinosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HUMAN; IDIOPATHIC PULMONARY ALVEOLAR PROTEINOSIS; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTRATION; SEX RATIO; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY ALVEOLAR PROTEINOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33645104086     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00810.x     Document Type: Conference Paper

References (34)

1. Rosen SH Castleman B Liebow AA Pulmonary alveolar proteinosis NEnglJMed 1958 258 1123 42
2. Dirksen U Hattenhorst U Schneider P et al. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure Blood 1998 92 1097 103
3. Nogee LM Genetics of the hydrophobic surfactant proteins BiochimBiophysActa 1998 1408 323 33
4. Dirksen U Nishinakamura R Groneck P et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression JClinInvest 1997 100 2211 17
5. Seymour JF Presneill JJ Pulmonary alveolar proteinosis: progress in the first 44 years AmJRespirCritCare Med 2002 166 215 35
6. Shah PL Hansell D Lawson PR Reid KB Morgan C Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis Thorax 2000 55 67 77
7. Stanley E Lieschke GJ Grail D et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology ProcNatlAcadSciUSA 1994 91 5592 6
8. Ikegami M Ueda T Hull W et al. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation AmJPhysiol 1996 270 L650 8
9. Reed JA Ikegami M Cianciolo ER et al. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice AmJPhysiol 1999 276 L556 63
10. Ikegami M Jobe AH Huffman Reed JA Whitsett JA Surfactant metabolic consequences of overexpression of GM-CSF in the epithelium of GM-CSF-deficient mice AmJPhysiol 1997 273 L709 14
11. Zsengeller ZK Reed JA Bachurski CJ et al. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice HumGeneTher 1998 9 2101 9
12. Huffman JA Hull WM Dranoff G Mulligan RC Whitsett JA Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice JClinInvest 1996 97 649 55
13. Carraway MS Ghio AJ Carter JD Piantadosi CA Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis AmJRespirCritCare Med 2000 161 1294 9
14. Seymour JF Dunn AR Vincent JM Presneill JJ Pain MC Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis NEnglJMed 1996 335 1924 5
15. Seymour JF Begley CG Dirksen U et al. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis Blood 1998 92 2657 67
16. Kavuru MS Sullivan EJ Piccin R Thomassen MJ Stoller JK Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis AmJRespirCritCare Med 2000 161 1143 8
17. Seymour JF Presneill JJ Schoch OD et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis AmJRespirCritCare Med 2001 163 524 31
18. Kitamura T Tanaka N Watanabe J et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony stimulating factor JExpMed 1999 190 875 80
19. Trapnell BC Whitsett JA Nakata K Pulmonary alveolar proteinosis NEnglJMed 2003 349 2527 39
20. Tazawa R Hamano E Arai T et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis AmJRespirCritCare Med 2005 171 1142 9
21. Arai T Hamano E Inoue Y et al. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF RespirMed 2004 98 1227 30
22. Nakajima M Manabe T Niki Y Matsushima T Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis Thorax 1998 53 809 11
23. Fujishima T Honda Y Shijubo N Takahashi H Abe S Increased carcinoembryonic antigen concentrations in sera and bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis Respiration 1995 62 317 21
24. Kuroki Y Tsutahara S Shijubo N et al. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis AmRevRespirDis 1993 147 723 9
25. Honda Y Kuroki Y Matsuura E et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids AmJRespirCritCare Med 1995 152 1860 6
26. Iyonaga K Suga M Yamamoto T Ichiyasu H Miyakawa H Ando M Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis EurRespirJ 1999 14 383 9
27. Bonfield TL John N Malur A et al. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression ClinImmunol 2005 114 79 85
28. Seymour JF Doyle IR Nakata K et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis Thorax 2003 58 252 7
29. Thomassen MJ Raychaudhuri B Bonfield TL et al. Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis Autoimmunity 2003 36 285 90
30. Kitamura T Uchida K Tanaka N et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis AmJRespirCritCare Med 2000 162 658 62
31. Kohno N Kyoizumi S Awaya Y Fukuhara H Yamakido M Akiyama M New serum indicator of interstitial pneumonitis activity: Sialylated carbohydrate antigen KL-6 Chest 1989 96 68 73
32. Inoue Y Barker E Daniloff E Kohno N Hiwada K Newman LS Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis AmJRespirCritCare Med 1997 156 109 15
33. Takahashi H Fujishima T Koba H et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent AmJRespirCritCare Med 2000 162 1109 14
34. Presneill JJ Nakata K Inoue Y Seymour JF Pulmonary alveolar proteinosis ClinChest Med 2004 25 593 613